Wall Street Zen Downgrades ReposiTrak (NYSE:TRAK) to Hold

ReposiTrak (NYSE:TRAK) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Friday.

Separately, Weiss Ratings reiterated a “hold (c+)” rating on shares of ReposiTrak in a report on Saturday, September 27th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock has an average rating of “Hold”.

ReposiTrak Stock Down 3.6%

ReposiTrak stock opened at $14.91 on Friday. The business’s 50-day simple moving average is $16.63. ReposiTrak has a 52 week low of $13.86 and a 52 week high of $25.01. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.03 and a current ratio of 6.03. The stock has a market capitalization of $272.55 million, a PE ratio of 42.60 and a beta of 0.44.

ReposiTrak (NYSE:TRAK) last posted its quarterly earnings data on Monday, September 29th. The company reported $0.09 earnings per share (EPS) for the quarter. ReposiTrak had a return on equity of 14.35% and a net margin of 30.55%.The firm had revenue of $5.76 million during the quarter.

Insiders Place Their Bets

In related news, CEO Randall K. Fields sold 4,700 shares of the stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $15.71, for a total transaction of $73,837.00. Following the completion of the sale, the chief executive officer directly owned 57,500 shares in the company, valued at $903,325. This represents a 7.56% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. In the last three months, insiders sold 88,500 shares of company stock worth $1,519,974. Corporate insiders own 44.00% of the company’s stock.

Institutional Investors Weigh In On ReposiTrak

Institutional investors have recently bought and sold shares of the stock. BNP Paribas Financial Markets boosted its holdings in ReposiTrak by 63.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock valued at $32,000 after acquiring an additional 634 shares during the period. Tower Research Capital LLC TRC boosted its holdings in ReposiTrak by 397.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock valued at $71,000 after acquiring an additional 2,892 shares during the period. R Squared Ltd purchased a new stake in ReposiTrak during the 2nd quarter valued at about $235,000. Rhumbline Advisers boosted its holdings in ReposiTrak by 69.1% during the 2nd quarter. Rhumbline Advisers now owns 18,036 shares of the company’s stock valued at $354,000 after acquiring an additional 7,371 shares during the period. Finally, Coldstream Capital Management Inc. boosted its holdings in ReposiTrak by 47,619.0% during the 2nd quarter. Coldstream Capital Management Inc. now owns 20,042 shares of the company’s stock valued at $394,000 after acquiring an additional 20,000 shares during the period. 27.35% of the stock is currently owned by hedge funds and other institutional investors.

About ReposiTrak

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.